Literature DB >> 32121132

Antioxidant and a-amylase Inhibitory Activities and Phytocompounds of Clausena indica Fruits.

Tran Dang Xuan1, Nguyen Thi Dieu Thuy1, Nguyen Van Quan1, Le Thu Trang1.   

Abstract

Background: Clausena indica fruit is commonly used for food ingredients and traditional medicines in tropical countries, however, information about its biological activities and chemical profiles has been inadequately reported.
Methods: In this study, a bio-guided fractionation of antioxidants and α-amylase inhibitors from hexane (MH) and ethyl acetate (ME) extracts of C. indica fruit (pericarp and seed) was carried out. Eleven fractions from MH (D1-D11) and 17 fractions from ME (T1-T17) were obtained from column chromatography over silica gel, which were then examined for anti-radical capacity by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays, and pancreatic α-amylase inhibition, a key enzyme linked to type 2 diabetes.
Results: Of isolated fractions, the fraction T4 revealed the most potent anti-DPPH activity (IC50 = 0.13 mg/mL), whereas T2 exhibits the strongest ABTS cation scavenging ability (IC50 = 0.31 mg/mL). In the enzymatic assay, the fractions D3 and T4 significantly inhibit the α-amylase reaction with IC50 values of 0.34 and 0.86 mg/mL, respectively. Remarkably, α-amylase suppression of T4 is close to acarbose and over four times stronger than palmitic acid, which are the well-known α-amylase inhibitors (IC50 = 0.07 and 1.52 mg/mL, respectively). The active constituents from fractions were identified by gas chromatography-mass spectrometry (GC-MS). The results show that the fraction D3 contains five major compounds, which are grouped in five classes consisting of fatty acids, phenols, benzodioxoles, alcohols, and sesquiterpenes. Among them, palmitic acid is the most dominant compound (32.64%), followed by 2R-acetoxymethyl-1,3,3-trimethyl-4t-(3-methyl-2-buten-1-yl)-1t-cyclohexanol (16.69%). Whilst, six major compounds belonging to fatty acid and coumarin classes are identified in the fraction T4. The most abundant compound in T4 is dentatin (47.32%), followed by palmitic acid (15.11%). Conclusions: This is the first finding that C. indica fruit can be a promising source for the development of natural antioxidant and antidiabetic agents. Additionally, the outcome reveals that dentatin, a known natural antineoplastic agent, can be feasibly exploited from C. indica fruit.

Entities:  

Keywords:  Clausena indica; a-amylase inhibitor; antidiabetes; antioxidants; fruits; gas chromatography-mass spectrometry

Year:  2020        PMID: 32121132     DOI: 10.3390/medicines7030010

Source DB:  PubMed          Journal:  Medicines (Basel)        ISSN: 2305-6320


  4 in total

1.  Hemin with Peroxidase Activity Can Inhibit the Oxidative Damage Induced by Ultraviolet A.

Authors:  Wenli Hui; Zhipeng Yang; Ke Fang; Mengdi Wu; Wenhua Mu; Cong Zhao; Dan Xue; Tengteng Zhu; Xiao Li; Ming Gao; Yunhua Lu; Kunping Yan
Journal:  Curr Issues Mol Biol       Date:  2022-06-10       Impact factor: 2.976

2.  Anti-Diabetes, Anti-Gout, and Anti-Leukemia Properties of Essential Oils from Natural Spices Clausena indica, Zanthoxylum rhetsa, and Michelia tonkinensis.

Authors:  Nguyen Van Quan; La Hoang Anh; Vu Quang Lam; Akiyoshi Takami; Rolf Teschke; Tran Dang Khanh; Tran Dang Xuan
Journal:  Molecules       Date:  2022-01-25       Impact factor: 4.411

3.  Cytotoxicity of Callerya speciosa Fractions against Myeloma and Lymphoma Cell Lines.

Authors:  Vu Quang Lam; La Hoang Anh; Nguyen Van Quan; Tran Dang Xuan; Ichiro Hanamura; Kaori Uchino; Sivasundaram Karnan; Akiyoshi Takami
Journal:  Molecules       Date:  2022-04-03       Impact factor: 4.411

4.  Phytochemical Profiling in Conjunction with In Vitro and In Silico Studies to Identify Human α-Amylase Inhibitors in Leucaena leucocephala (Lam.) De Wit for the Treatment of Diabetes Mellitus.

Authors:  Senthil Renganathan; Sakthivel Manokaran; Preethi Vasanthakumar; Usha Singaravelu; Pok-Son Kim; Arne Kutzner; Klaus Heese
Journal:  ACS Omega       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.